Novel Nonsymmetrically p -Benzyl-Substituted (Benz)imidazole N -Heterocyclic Carbene-Silver(I) Acetate Complexes: Synthesis and Biological Evaluation

  • Hackenberg F
  • Deally A
  • Lally G
  • et al.
N/ACitations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nonsymmetrically substituted N -heterocyclic carbene (NHC) precursors 1a – d and 3a – d were synthesised by first reacting 1H-(benz)imidazole with p -cyanobenzyl bromide to give 4-(1H-imidazole-1-ylmethyl)benzonitrile ( 1 ) and 4-(1H-benzimidazole-1-ylmethyl)benzonitrile ( 3 ) and afterwards introducing benzyl bromide, 1-(bromomethyl)-4-methylbenzene, 1-(bromomethyl)-4-methoxybenzene, and methyl 4-(bromomethyl)benzoate. The NHC-silver(I) acetate complexes (1-benzyl-3-(4-cyanobenzyl)-2,3-dihydro-1H-imidazole-2-ylidene) silver(I) acetate ( 2a ), (1-(4-cyanobenzyl)-3-(4-methylbenzyl)-2,3-dihydro-1H-imidazole-2-ylidene) silver(I) acetate ( 2b ), (1-(4-cyanobenzyl)-3-[4-(methoxycarbonyl)benzyl]-2,3-dihydro-1H-imidazole-2-ylidene) silver(I) acetate ( 2c ), (1-benzyl-3-(4-cyanobenzyl)-2,3-dihydro-1H-benzimidazole-2-ylidene) silver(I) acetate ( 4a ), (1-(4-cyanobenzyl)-3-(4-methylbenzyl)-2,3-dihydro-1H-benzimidazole-2-ylidene) silver(I) acetate ( 4b ), (1-(4-cyanobenzyl)-3-(4-methoxybenzyl)-2,3-dihydro-1H-benzimidazole-2-ylidene) silver(I) acetate ( 4c ), and (1-(4-cyanobenzyl)-3-[4-(methoxycarbonyl)benzyl]-2,3-dihydro-1H-benzimidazole-2-ylidene) silver(I) acetate ( 4d ) were yielded by reacting these NHC precursors with silver(I) acetate. The silver(I) acetate complex 4b was characterised by single crystal X-ray diffraction. Preliminary in vitro antibacterial studies against the Gram-positive bacteria Staphylococcus aureus and the Gram-negative bacteria Escherichia coli , using the Kirby-Bauer disc diffusion method, were carried out on the seven NHC-silver(I) acetate complexes 2a – c and 4a – d . Also the IC 50 values of these seven complexes were determined by an MTT-based assay against the human renal cancer cell line Caki-1. The complexes 2a – c and 4a – c revealed the following IC 50 values, respectively, 25 (±1), 15 (±2), 5.4 (±0.8), 16 (±2), 7.1 (±1), 20 (±4), and 14 (±1) μ M.

Cite

CITATION STYLE

APA

Hackenberg, F., Deally, A., Lally, G., Malenke, S., Müller-Bunz, H., Paradisi, F., … Tacke, M. (2012). Novel Nonsymmetrically p -Benzyl-Substituted (Benz)imidazole N -Heterocyclic Carbene-Silver(I) Acetate Complexes: Synthesis and Biological Evaluation. International Journal of Inorganic Chemistry, 2012, 1–13. https://doi.org/10.1155/2012/121540

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free